I agree that this site is using cookies. You can find further informations here.
X
Reeves, Brandi
74  results:
Search for persons X
?
1

Daratumumab-based quadruplet therapy for transplant-eligibl..:

Callander, Natalie S. ; Silbermann, Rebecca ; Kaufman, Jonathan L....
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Blood cell JAKtivation aggravates cerebral venous thrombosi:

Reeves, Brandi
Blood Advances.  8 (2024)  12 - p. 3327-3329 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Daratumumab in transplant-eligible patients with newly diag..:

Chari, Ajai ; Kaufman, Jonathan L. ; Laubach, Jacob...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

Health‐related quality of life in transplant‐eligible patie..:

Silbermann, Rebecca ; Laubach, Jacob ; Kaufman, Jonathan L....
American Journal of Hematology.  99 (2024)  7 - p. 1257-1268 , 2024
Link: https://doi.org/10.1002/..
 
?
5

Post hoc analysis of daratumumab plus lenalidomide, bortezo..:

Nooka, Ajay K. ; Kaufman, Jonathan L. ; Rodriguez, Cesar...
British Journal of Haematology.  204 (2024)  6 - p. 2227-2232 , 2024
Link: https://doi.org/10.1111/..
 
?
6

Multivariable Analyses of Prognostic Factors for Progressio..:

Hassoun, Hani ; Jacobus, Susanna J ; Richardson, Paul G....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S396-S397 , 2023
Link: https://doi.org/10.1016/..
 
?
7

HTRS2023.O8B.1 HIF-1 inhibition attenuates venous thrombosi..:

Reeves, Brandi ; Ghosh, Shatadal ; Moliterno, Alison..
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100214 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Stem Cell Mobilization Yields with Daratumumab- and Lenalid..:

Chhabra, Saurabh ; Callander, Natalie ; Watts, Nicole L....
Transplantation and Cellular Therapy.  29 (2023)  3 - p. 174.e1-174.e10 , 2023
Link: https://doi.org/10.1016/..
 
?
9

POSTER: MPN-559 Bromodomain and Extra-terminal (BET) Inhibi..:

Watts, Justin ; Hunter, Anthony ; Iurlo, Alessandra...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S196 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB0..:

Watts, Justin M. ; Hunter, Anthony M. ; Iurlo, Alessandra...
HemaSphere.  7 (2023)  S3 - p. e1792906 , 2023
Link: https://doi.org/10.1097/..
 
?
11

P-164 Reduction in disease symptoms/impacts after daratumum..:

Silbermann, Rebecca ; Laubach, Jacob ; Kaufman, Jonathan...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S125-S126 , 2023
Link: https://doi.org/10.1016/..
 
?
12

MPN-559 Bromodomain and Extra-Terminal (BET) Inhibitor INCB..:

Watts, Justin ; Hunter, Anthony ; Iurlo, Alessandra...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S403-S404 , 2023
Link: https://doi.org/10.1016/..
 
?
13

A Plain Language Summary of Daratumumab Plus Lenalidomide/B..:

Nooka, Ajay K ; Kaufman, Jonathan L ; Rodriguez, Cesar...
Future Oncology.  18 (2022)  40 - p. 4443-4456 , 2022
Link: https://doi.org/10.2217/..
 
?
14

P-219: Daratumumab (DARA) + lenalidomide/bortezomib/dexamet..:

Nooka, Ajay ; Kaufman, Jonathan ; Rodriguez, Cesar...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S155-S156 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Daratumumab plus lenalidomide, bortezomib and dexamethasone..:

Sborov, Douglas W. ; Baljevic, Muhamed ; Reeves, Brandi...
British Journal of Haematology.  199 (2022)  3 - p. 355-365 , 2022
Link: https://doi.org/10.1111/..
 
1-15